Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Congestive Heart Failure Clinical Trials

A listing of Congestive Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (9) clinical trials

The purpose of this study is to evaluate the effect of LCZ696 compared to valsartan on cognitive function in patients with heart failure and preserved ejection fraction (HFpEF).


High Flow Nasal Oxygen and Acute Left Heart Failure

The anticipated number of patient subjects will reach 120 in the study. The patient's condition should be informed to his/her next of kin and then agree to signs the informed consent. When passing spontaneous breathing trials and removing tracheal tube, the patients should be divided into two groups by random ...

Phase N/A

Relationship Between LINQ Subcutaneous Impedance and Right-sided Hemodynamic Measurements

The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized.

Phase N/A

CLUSTER-HF: a Randomized Controlled Trial of Lung Ultrasound Guided Therapy in Heart Failure

Introduction: Heart failure is the leading cause of hospitalization among adults >65 years of age. Discharge from a heart failure hospitalization is followed by a 30 day readmission rate of 24%. Readmissions for heart failure are typically preceded by a gradual rise in ventricular filling pressures that begins days or ...

Phase N/A

Community Pharmacy Medication Therapy Management for Heart Failure

The pharmacists (n=53) of the 20 community pharmacies located in Newport and Bristol Counties will serve as the CBRN intervention sites. The investigators will also enroll 30 independently living community dwelling subjects who are prescribed at least 1 cardiovascular medication for HF and 3 additional chronic medications after discharge from ...

Phase N/A

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

Thirty-five heart-failure patients will be included in a prospective, monocentric, active-controlled, double-blind, cross-over study with randomized sequence of treatments sacubitril+valsartan or valsartan alone. After open-label dose finding and washout patients will be randomly assigned to the treatment sequence [sac+val --> val] or [val --> sac+val]. The two treatment periods of ...


Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

Patients with chronic heart failure (NYHA II-IV) and serum potassium > 5.0 mmol/L or at high risk of developing hyperkalaemia will be enrolled. Patients signing informed consent will be screened for up to 14 days. Patients meeting the inclusion criteria, but not the exclusion criteria, are then randomized in a ...


Clinical Evaluation of the TRVD System in ADHF

A prospective, multi-national, open-label clinical study which is conducted to asses the safety, feasibility and performance of the TRVD System in hospital-admitted patients with Acute Decompensated Heart Failure (ADHF) and evidence of reduced left ventricular ejection fraction. The study will include patients who present with significant venous congestion, as evidenced ...

Phase N/A

Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure

The purpose of this study is to evaluate the effect of Cardiac Sympathetic Blockade on Mortality, re-hospitalization rate, symptoms, quality of life, exercise tolerance, cardiac structure, systolic function, electrical activities and concentration of B - type natriuretic peptide precursor in patients with Chronic Heart Failure.

Phase N/A